Nasopharyngeal carriage of pneumococcal serotypes in healthy pre-school aged children after 7-valent pneumococcal vaccine;Serotipos de neumococo en nasofaringe de niños preescolares sanos tras la vacunación antineumocócica conjugada heptavalente

Medicina Clinica

Volumn 137, Issue 1, 2011, Pages 1-7

  García Vera, César ^a,b   Ruiz Andrés, María Ángeles ^b,c   Arana Navarro, Teresa ^a,b   Moneo Hernández, Isabel ^b,d   Castillo Laita, José Antonio ^b,e   MacIpe Costa, Rosa ^e   Revillo Pinilla, María José ^c  

^a Centro de Salud J R Muñoz Fernández   (Spain)

^b INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^c HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^d Centro de Salud Delicias Norte   (Spain)

^e Centro de Salud Fuentes de Ebro   (Spain)

Author keywords

Child; Drug resistance bacterial; Heptavalent pneumococcal conjugate vaccine; Nasopharynx; Pre school; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; CHILD; CONFIDENCE INTERVAL; HEALTH CENTER; HUMAN; HUMAN EXPERIMENT; LOGISTIC REGRESSION ANALYSIS; NASOPHARYNX; NORMAL HUMAN; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; RISK; SEROTYPE; SIBLING; SPAIN; UPPER RESPIRATORY TRACT INFECTION;

CARRIER STATE; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; NOSE; PHARYNX; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 79958049720     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2010.09.051     Document Type: Article

References (34)

1. Centers for Disease Control and Prevention (CDC) Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine - United States, 1997-2006 MMWR Morb Mortal Wkly Rep 58 2009 1 4
2. A. Reingold, J. Hadler, M.M. Farley, L. Harrison, R. Lynfield, and C. Lexau Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction. Eight States 1998-2005 MMWR Morb Mortal Wkly Rep 57 2008 144 147
3. M. Pavia, A. Bianco, C.G. Nobile, P. Marinelli, and I.F. Angelillo Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis Pediatrics 123 2009 e1103 1110
4. S. Rückinger, M. van der Linden, R.R. Reinert, R. von Kries, F. Burckhardt, and A. Siedler Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany Vaccine 27 2009 4136 4141
5. The UK Health Protection Agency. Current Epidemiology of Invasive Pneumococcal Disease (IPD). Disponible en: http://www.hpa.org.uk/HPA/Topics/ InfectiousDiseases/InfectionsAZ/1220341771909/
6. R.J. Singleton, T.W. Hennessy, L.R. Bulkow, L.L. Hammitt, T. Zulz, and D.A. Hurlburt Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage JAMA 297 2007 1784 1792 (Pubitemid 46658647)
7. A. Fenoll, J.J. Granizo, L. Aguilar, M.J. Giménez, L. Aragoneses-Fenoll, and G. Hanquet Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007 J Clin Microbiol 47 2009 1012 1020
8. A. Barricarte, A. Gil-Setas, L. Torroba, J. Castilla, A. Petit, and I. Polo Invasive pneumococcal disease in children younger than 5 years in Navarra, Spain (2000-2005). Impact of the conjugate vaccine Med Clin (Barc) 129 2007 41 45 (Pubitemid 47394720)
9. D.S. Shouval, D. Greenberg, N. Givon-Lavi, N. Porat, and R. Dagan Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis Pediatr Infect Dis J 25 2006 602 627
10. A.B. Brueggemann, T.E. Peto, D.W. Crook, J.C. Butler, K.G. Kristinsson, and B.G. Spratt Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children J Infect Dis 190 2004 1203 1211 (Pubitemid 39287745)
11. R. Dagan, and K.P. Klugman Impact of conjugate pneumococcal vaccines on antibiotic resistance Lancet Infect Dis 8 2008 785 795
12. B. Dunais, P. Bruno, H. Carsenti-Dellamonica, P. Touboul, P. Dellamonica, and C. Pradier Trends in nasopharyngeal carriage of Streptococcus pneumoniae among children attending daycare centers in southeastern France from 1999 to 2006 Pediatr Infect Dis J 27 2008 1033 1035
13. A.B. Brueggemann, D.T. Griffiths, E. Meats, T. Peto, D.W. Crook, and B.G. Spratt Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential J Infect Dis 187 2003 1424 1432 (Pubitemid 36549688)
14. D. Bogaert, R. De Groot, and P.W. Hermans Streptococcus pneumoniae colonisation: the key to pneumococcal disease Lancet Infect Dis 4 2004 144 154 (Pubitemid 38293138)
15. B. López, M.D. Cima, F. Vázquez, A. Fenoll, J. Gutiérrez, and C. Fidalgo Epidemiological study of Streptococcus pneumoniae carriers in healthy primary-school children Eur J Clin Microbiol Infect Dis 18 1999 771 776
16. D. Sánchez-Tatay, L.A. Arroyo, D. Tarragó, M.J. Lirola, A. Porras, and A. Fenoll Antibiotic susceptibility and molecular epidemiology of nasopharyngeal pneumococci from Spanish children Clin Microbiol Infect 14 2008 797 801
17. E. Calbo, A. Díaz, E. Cañadell, J. Fábrega, S. Uriz, and M. Xercavins Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine Clin Microbiol Infect 12 2006 867 872 (Pubitemid 44151286)
18. K.L. O'Brien, H. Nohynek World Health Organization Pneumococcal Vaccine Trials Carriage Working Group Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae Pediatr Infect Dis J 22 2003 e1 11
19. Clinical Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 7 h ed. CLSI document M2-A9. Clinical Laboratory Standards. Wayne, Pa: Institute; 2008.
20. Clinical Laboratory Standards Institute. Performance standars for antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 8th Informational Supplement. CLSI document M100-S18. Clinical Laboratory Standards. Wayne, Pa: Institute; 2008.
21. R. Mera, L.A. Miller, T.R. Fritsche, and R.N. Jones Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine Microb Drug Resist 14 2008 101 107
22. J.J. Picazo Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines Clin Microbiol Infect 15 Suppl3 2009 4 6
23. J. Aristegui, E. Bernaola, I. Pocheville, C. García, L. Arranz, and G. Durán Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine Eur J Clin Microbiol Infect Dis 26 2007 303 310 (Pubitemid 46716801)
24. C. Muñoz-Almagro, I. Jordan, A. Gene, C. Latorre, J.J. Garcia-Garcia, and R. Pallares Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine Clin Infect Dis 46 2008 174 182 (Pubitemid 351269154)
25. F. Artiles, I. Horcajada, A.M. Cañas, I. Alamo, A. Bordes, and A. González Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands) Enferm Infecc Microbiol Clin 27 2009 14 21
26. J. Casado-Flores, C. Rodrigo, J. Arístegui, J.M. Martinón, A. Fenoll, and C. Mendez Decline in pneumococcal meningitis in Spain after introduction of the heptavalent pneumococcal conjugate vaccine Pediatr Infect Dis J 27 2008 1020 1022
27. J. Benito-Fernández, S.M. Raso, I. Pocheville-Gurutzeta, J. Sánchez-Etxaniz, B. Azcunaga-Santibañez, and S. Capapé-Zache Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain Pediatr Infect Dis J 26 2007 667 671 (Pubitemid 47424633)
28. M.A. San José González, and P. Méndez Fernández Vacuna conjugada neumocócica heptavalente: ¿luces y sombras? Rev Pediatr Aten Primaria 10 2008 467 488
29. I. Obando, C. Muñoz-Almagro, L.A. Arroyo, D. Tarrago, D. Sanchez-Tatay, and D. Moreno-Perez Pediatric parapneumonic empyema, Spain Emerg Infect Dis 14 2008 1390 1397
30. S.Y. Park, M.R. Moore, D.L. Bruden, T.B. Hyde, A.L. Reasonover, and M. Harker-Jones Impact of conjugate vaccine on transmission of antimicrobial- resistant Streptococcus pneumoniae among Alaskan children Pediatr Infect Dis J 27 2008 335 340 (Pubitemid 351483069)
31. S.S. Huang, R. Platt, S.L. Rifas-Shiman, S.I. Pelton, D. Goldmann, and J.A. Finkelstein Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004 Pediatrics 116 2005 e408 413
32. E.V. Millar, J.P. Watt, M.A. Bronsdon, J. Dallas, R. Reid, and M. Santosham Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members Clin Infect Dis 47 2008 989 996
33. D.J. Farrell, K.P. Klugman, and M. Pichichero Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States Pediatr Infect Dis J 26 2007 123 128 (Pubitemid 46183361)
34. F. Ghaffar, T. Barton, J. Lozano, L.S. Muniz, P. Hicks, and V. Gan Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life Clin Infect Dis 39 2004 930 938 (Pubitemid 39313446)